Search details
1.
Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial.
Circulation
; 147(25): 1891-1901, 2023 06 20.
Article
in English
| MEDLINE | ID: mdl-37154020
2.
Association of Bleeding Severity With Mortality in Extended Thromboprophylaxis of Medically Ill Patients in the MAGELLAN and MARINER Trials.
Circulation
; 145(19): 1471-1479, 2022 05 10.
Article
in English
| MEDLINE | ID: mdl-35389229
3.
Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.
N Engl J Med
; 379(12): 1118-1127, 2018 Sep 20.
Article
in English
| MEDLINE | ID: mdl-30145946
4.
Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study.
Am Heart J
; 235: 12-23, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33577800
5.
Bronchial mucosal IFN-α/ß and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations.
J Allergy Clin Immunol
; 143(1): 114-125.e4, 2019 01.
Article
in English
| MEDLINE | ID: mdl-29698627
6.
Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study.
J Allergy Clin Immunol
; 141(4): 1220-1230, 2018 04.
Article
in English
| MEDLINE | ID: mdl-28734844
7.
A phase 2a study of toreforant, a histamine H4 receptor antagonist, in eosinophilic asthma.
Ann Allergy Asthma Immunol
; 121(5): 568-574, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30102965
8.
Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.
J Allergy Clin Immunol
; 140(3): 710-719, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28089872
9.
A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma.
Hum Mol Genet
; 24(11): 3005-20, 2015 Jun 01.
Article
in English
| MEDLINE | ID: mdl-25586491
10.
Hospital-based use of thromboprophylaxis in patients with COVID-19.
Lancet
; 395(10234): e75, 2020 05 02.
Article
in English
| MEDLINE | ID: mdl-32330428
11.
Thromboprophylaxis after Hospitalization for Medical Illness.
N Engl J Med
; 379(23): 2280, 2018 12 06.
Article
in English
| MEDLINE | ID: mdl-30575454
12.
Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study.
Respir Res
; 17(1): 165, 2016 12 15.
Article
in English
| MEDLINE | ID: mdl-27978840
13.
Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure.
Am J Respir Crit Care Med
; 191(7): 786-95, 2015 Apr 01.
Article
in English
| MEDLINE | ID: mdl-25594886
14.
CC-chemokine ligand 2 inhibition in idiopathic pulmonary fibrosis: a phase 2 trial of carlumab.
Eur Respir J
; 46(6): 1740-50, 2015 Dec.
Article
in English
| MEDLINE | ID: mdl-26493793
15.
Transcriptomic and methylomic features in asthmatic and nonasthmatic twins.
Allergy
; 75(4): 989-992, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31758558
16.
Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.
Pulm Pharmacol Ther
; 30: 32-43, 2015 Feb.
Article
in English
| MEDLINE | ID: mdl-25445932
17.
Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis.
Eur Respir J
; 44(5): 1296-307, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25034562
18.
Quantitative Benefit-Risk Evaluation of Rivaroxaban in Patients After Peripheral Arterial Revascularization: The VOYAGER PAD Trial.
J Am Heart Assoc
; 13(8): e032782, 2024 Apr 16.
Article
in English
| MEDLINE | ID: mdl-38563380
19.
Updated Renal Dosage Recommendations for Rivaroxaban in Patients Experiencing or at Risk of Thromboembolic Disease.
Am J Cardiovasc Drugs
; 23(3): 247-255, 2023 May.
Article
in English
| MEDLINE | ID: mdl-37115488
20.
Antithrombotic Prophylaxis with Rivaroxaban in Patients with Prehospital COVID-19: A Meta-analysis of Two Placebo-Controlled Trials.
Thromb Haemost
; 2023 Dec 21.
Article
in English
| MEDLINE | ID: mdl-37995748